Share-based Payment Arrangement, Expense in USD of DEXCOM INC from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Dexcom Inc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q3 2025.
  • Dexcom Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $45.1M, a 3.92% increase year-over-year.
  • Dexcom Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $168M, a 2.38% increase year-over-year.
  • Dexcom Inc annual Share-based Payment Arrangement, Expense for 2024 was $170M, a 13% increase from 2023.
  • Dexcom Inc annual Share-based Payment Arrangement, Expense for 2023 was $151M, a 19.2% increase from 2022.
  • Dexcom Inc annual Share-based Payment Arrangement, Expense for 2022 was $127M, a 11.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

DEXCOM INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $168M $45.1M +$1.7M +3.92% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 $166M $45.3M +$600K +1.34% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 $166M $34.2M -$4.8M -12.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $170M $43.3M +$6.4M +17.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-18
Q3 2024 $164M $43.4M +$4.4M +11.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 $160M $44.7M +$5M +12.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 $155M $39M +$3.8M +10.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 $151M $36.9M +$2.9M +8.53% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-18
Q3 2023 $148M $39M +$8.2M +26.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 $140M $39.7M +$7.1M +21.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $133M $35.2M +$6.1M +21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $127M $34M +$7.7M +29.3% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-18
Q3 2022 $119M $30.8M +$3.3M +12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $116M $32.6M +$1M +3.17% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $115M $29.1M +$1.1M +3.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $113M $26.3M -$7.8M -22.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 $121M $27.5M -$3.2M -10.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $124M $31.6M +$900K +2.93% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $124M $28M +$4.1M +17.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $119M $34.1M +$10.5M +44.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $109M $30.7M +$6.3M +25.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $103M $30.7M +$1M +3.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $102M $23.9M -$1.1M -4.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $103M $23.6M -$1M -4.07% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-14
Q3 2019 $104M $24.4M -$2.7M -9.96% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 $106M $29.7M +$4.1M +16% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 $102M $25M +$400K +1.63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q4 2018 $102M $24.6M -$81.6M -76.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-11
Q3 2018 $184M $27.1M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $25.6M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $24.6M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $106M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q4 2014 $50M $14.3M +$7.7M +117% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $42.3M $13.8M +$7.2M +109% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $35.1M $13.2M +$6.8M +106% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $28.3M $8.7M +$3.7M +74% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $24.6M $6.6M +$2M +43.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 $22.6M $6.6M +$1.7M +34.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $20.9M $6.4M +$1.6M +33.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $19.3M $5M +$900K +22% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $18.4M $4.6M +$900K +24.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $17.5M $4.9M +$1.2M +32.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $16.3M $4.8M +$1.2M +33.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $15.1M $4.1M +$1.6M +64% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-01
Q4 2011 $13.5M $3.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $3.7M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $3.6M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $2.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02

DEXCOM INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $170M +$19.6M +13% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $151M +$24.3M +19.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $127M +$13.1M +11.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $113M -$6M -5.03% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 $119M +$16.7M +16.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $103M +$800K +0.79% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-14
2018 $102M -$4.3M -4.05% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $106M -$4.6M -4.15% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $111M +$28.1M +34% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 $82.7M +$32.7M +65.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $50M +$25.4M +103% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $24.6M +$6.2M +33.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $18.4M +$4.9M +36.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 $13.5M +$4.1M +43.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $9.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.